Antimicrobial therapy during ECMO - customised dosing with therapeutic drug monitoring: The way to go?

Affiliations

• ¹ University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, QLD, Australia.
• ² Adult Intensive Care Services, The Prince Charles Hospital, Chermside, Australia; Critical Care Research Group, Centre of Research Excellence for Advanced Cardiorespiratory Therapies Improving Organ Support (ACTIONS), The University of Queensland, Brisbane, QLD, Australia.
• ³ University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, QLD, Australia; Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia; Faculty of Medicine, The University of Queensland, Brisbane, University of Queensland Centre for Clinical Research (UQCCR), QLD, Australia. Electronic address: j.roberts2@uq.edu.au.